Also, because APP is located in C21, a connection between gene dosage and AD is seen in 21 trisomy, and Down syndrome adults have increased risk to develop AD and show neuropathological changes of AD at age 40 (Wiseman et al., 2015; Lott and Head, 2019). The gene discussed is APP; the disease is Down syndrome.